New study checks psoriasis drug safety for kids
NCT ID NCT06088199
First seen Nov 01, 2025 · Last updated May 12, 2026 · Updated 25 times
Summary
This study looks at how safe the drug apremilast is for children aged 6 to 17 with mild to moderate plaque psoriasis. About 51 kids will take the drug and be monitored for side effects, growth, and development. The goal is to make sure the treatment is safe for younger patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PLAQUE PSORIASIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Affiliated Dermatology
Scottsdale, Arizona, 85255, United States
-
Austin Institute for Clinical Research
Pflugerville, Texas, 78660, United States
-
Avance Clinical Trials
Laguna Niguel, California, 92677, United States
-
Boeson Research
Missoula, Montana, 59804, United States
-
California Dermatology Institute
Thousand Oaks, California, 91320, United States
-
Ciocca Dermatology
Miami, Florida, 33173, United States
-
Clear Dermatology
Scottsdale, Arizona, 85255, United States
-
Clinical Science Institute
Santa Monica, California, 90404, United States
-
Dawes Fretzin Clinical Research Group, LLC
Indianapolis, Indiana, 46250, United States
-
Dermatology Research Center of Oklahoma, PLLC
Tulsa, Oklahoma, 74132, United States
-
Dermatology and Skin Cancer Center of Lees Summit
Lee's Summit, Missouri, 64064, United States
-
Empire Dermatology
East Syracuse, New York, 13057, United States
-
Endeavor Health Clinical Trials Center
Skokie, Illinois, 60077, United States
-
Frontier Derm Partners
Mill Creek, Washington, 98012, United States
-
Great Lakes Research Group Inc- Sheffield
Bay City, Michigan, 48706, United States
-
Henry Ford Medical Center - New Center One
Detroit, Michigan, 48202, United States
-
Hightower Clinical LLC
Oklahoma City, Oklahoma, 73120, United States
-
Johnson Dermatology Clinic
Fort Smith, Arkansas, 72916, United States
-
MedDerm Associates
San Diego, California, 92103, United States
-
Medical University of South Carolina
Charleston, South Carolina, 29425, United States
-
OptiSkin Medical
New York, New York, 10029, United States
-
Oregon Health and Science University
Portland, Oregon, 97239, United States
-
Pediatric Skin Research LLC
Coral Gables, Florida, 33146, United States
-
Southern Indiana Clinical Trials
New Albany, Indiana, 47150, United States
-
State University of New York, Downstate Medical Center
Manhasset, New York, 11030, United States
-
Stride Clinical Research LLC
Sugar Land, Texas, 77479, United States
-
Studies in Dermatology LLC
Cypress, Texas, 77429, United States
-
University of Alabama at Birmingham
Birmingham, Alabama, 35233, United States
-
University of California Irvine
Orange, California, 92868, United States
-
University of South Florida
Tampa, Florida, 33612, United States
Conditions
Explore the condition pages connected to this study.